Sumeet Sud shares news of GSK’s Voltaren Arthritis Pain Gel

FDA has approved Glaxo Smith Cline (GSK’s) Voltaren Arthritis Pain (diclofenac sodium topical gel) as an-over-the-counter (OTC) product for temporary relief of arthritis pain in hand, wrist, elbow, foot, ankle or knee in adults. With the FDA’s approval, Voltaren becomes the first and only prescription strength nonsteroidal anti-inflammatory (NSID) topical gel for arthritis pain available OTC in the United States. Voltaren is currently the number one OTC topical pain relief band globally, and now it expands its availability in the US. The active ingredient in Voltaren, diclofenac sodium, is an effective medicine that is clinically proven to relieve joint pain due to arthritis. Voltaren penetrates through the skin at the application site to deliver arthritis pain relief. GSK anticipates Voltaren Arthritis Pain will be available on US shelves in Spring 2020.